Epicardial adipose tissue (EAT) is related to the presence of coronary artery disease (CAD). Increased γ-glutamyltransferase (GGT) activity is associated with atherosclerosis. We assessed the relationship between EAT and serum GGT activity in addition to cardiovascular risk factors in patients with stable anginal symptoms. Consecutive patients (n = 120) who underwent coronary angiography were included. Epicardial adipose tissue thickness was measured by echocardiography. Serum GGT activity was measured by enzymatic colorimetric assay. Epicardial adipose tissue thickness and serum GGT activity were higher in patients with CAD (n = 83). Patients with metabolic syndrome (n = 83) were found to have higher EAT thickness. Serum GGT activity was independently associated with EAT values. In conclusion, echocardiographic EAT was significantly higher in patients with CAD and serum GGT activity correlated with EAT thickness.
PeirisANSothmannMSHoffmannRG. Adiposity, fat distribution, and cardiovascular risk. Ann Intern Med. 1989;110(11):867–872.
2.
VisscherTLSeidellJCMolariusAvan der KuipDHofmanAWittemanJC. A comparison of body mass index, waist-hip ratio and waist circumference as predictors of all-cause mortality among the elderly: the Rotterdam study. Int J Obes Relat Metab Disord. 2001;25:1730–1735.
3.
KonishiMSugiyamaSSugamuraK. Association of pericardial fat accumulation rather than abdominal obesity with coronary atherosclerotic plaque formation in patients with suspected coronary artery disease. Atherosclerosis. 2010;209(2):573–578.
4.
UenoKAnzaiTJinzakiM. Increased epicardial fat volume quantified by 64-multidetector computed tomography is associated with coronary atherosclerosis and totally occlusive lesions. Circ J. 2009;73(10):1927–1933.
5.
AhnSGLimHSJoeDY. Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart. 2008;94(3):e7.
6.
IacobellisGRibaudoMCAssaelF. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003;88(11):5163–5168.
7.
PaolicchiAMinottiGTonarelliP. Gamma-glutamyl transpeptidase-dependent iron reduction an LDL oxidation—a potential mechanism in atherosclerosis. J Investig Med. 1999;47(3):151–160.
8.
EmdinMPassinoCMichelassiC. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J. 2001;22(19):1802–1807.
9.
LeeDHJacobsDRJrGrossM. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem. 2003;49(8):1358–1366.
10.
PaolicchiAEmdinMGhliozeniE. Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation. 2004;109(11):1440.
11.
LiebermanMWBarriosRCarterBZ. Gamma-Glutamyl transpeptidase. What does the organization and expression of a multipromoter gene tell us about its functions?. Am J Pathol. 1995;147(5):1175–1185.
12.
BruckertEGiralPRatziuV. A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients. Metabolism. 2002;51(8):1071–1076.
13.
OnatAHergençGKarabulutA. Serum gamma glutamyltransferase as a marker of metabolic syndrome and coronary disease likelihood in nondiabetic middle-aged and elderly adults. Prev Med. 2006;43(2):136–139.
14.
SakugawaHNakayoshiTKobashigawaK. Metabolic syndrome is directly associated with gamma glutamyl transpeptidase elevation in Japanese women. World J Gastroenterol. 2004;10(7):1052–1055.
15.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–3421.
16.
IacobellisGWillensHJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr. 2009;22(12):1311–1319.
17.
ChaldakovGNStankulovISAloeL. Subepicardial adipose tissue in human coronary atherosclerosis: another neglected phenomenon. Atherosclerosis. 2001;154(1):237–238.
18.
ErogluSSadeLEYildirirA. Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr Metab Cardiovasc Dis. 2009;19(3):211–217.
19.
MazurekTZhangLZalewskiA. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108(20):2460–2466.
20.
ChengKHChuCSLeeKT. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond). 2008;32(2):268–274.
21.
AhnSGLimHSJoeDY. Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart. 2008;94:e7.
JeongJWJeongMHYunKH. Echocardiographic epicardial fat thickness and coronary artery disease. Circ J. 2007;71(4):536–539.
24.
MoriyaSNagataSYokoyamaH. Expression of gamma-glutamyl transpeptidase mRNA after depletion of glutathione in rat liver. Alcohol Alcohol Suppl. 1994;29(1):107–111.
WatanabeMTaketaKIzumiMNagashimaH. Association of gamma-glutamyltransferase with plasma lipoprotein and lipid-protein complex in cholestasis. Hepatogastroenterology. 1984;31(5):204–207.
27.
AkpekMElcikDKalayN. The prognostic value of serum gama-glutamyl transferase activity on admission in patients with STEMI undergoing primary PCI. Angiology. 2012.;DOI: 10.1177/0003319711431880
28.
DemirkanBGurayYGurayUTurakOHajroEKorkmazS. The relationship between saphenous coronary bypass graft occlusion and serum gamma-glutamyltransferase activity. Turk Kardiyol Dern Ars. 2010;38(5):321–326.
29.
YamadaYIshizakiMKidoTHondaRTsuritaniIYamayaH. Relationship between serum gamma-glutamyl transpeptidase activity and blood pressure in middle-aged male and female non-drinkers. J Hum Hypertens. 1990;4(6):609–614.
30.
Van BarneveldTSeidellJCTraagNHautvastJG. Fat distribution and gamma-glutamyl transferase in relation to serum lipids and blood pressure in 38-year old Dutch males. Eur J Clin Nutr. 1989;43(12):809–818.
31.
ClarkJMBrancatiFLDiehlAM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98(5):960–967.
32.
NakanishiNSuzukiKTataraK. Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care. 2004;27(6):1427–1432.
33.
NakanishiNNishinaKLiWSatoMSuzukiKTataraK. Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. J Intern Med. 2003;254(3):287–295.
34.
AndréPBalkauBVolSCharlesMAEschwègeE. DESIR Study Group. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. Diabetes Care. 2007;30(9):2355–2361.
